In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...

So far this month, Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, and Bellevue-based health care tech company Truveta have raised rounds of $175 million and ...

North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...

Sanofi S.A. Part Cert-1.97% €8.03M ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.